1. Home
  2. Products
  3. Customized ADCs
  4. ROR1
  5. Anti-ROR1 scFv-Fc-Sec ADC

Anti-ROR1 scFv-Fc-Sec ADC (CAT#: ADC-W-434)

This ADC product is comprised of an anti-ROR1 scFv-Fc (clone R11) conjugated via a engineered selenocysteine (Sec) residue linker to a drug.

  • Product Information
  • ADC Target
  • ADC Antibody
  • ADC Linker
  • Antibody clone #
  • R11
  • Name
  • ROR1
  • Alternative Names
  • ROR1; receptor tyrosine kinase-like orphan receptor 1; NTRKR1; dJ537F10.1; tyrosine-protein kinase transmembrane receptor ROR1; neurotrophic tyrosine kinase, receptor-related 1;
  • Target Entrez Gene ID
  • 4919
  • Overview
  • This gene encodes a receptor tyrosine kinase-like orphan receptor that modulates neurite growth in the central nervous system. The encoded protein is a glycosylated type I membrane protein that belongs to the ROR subfamily of cell surface receptors. It is a pseudokinase that lacks catalytic activity and may interact with the non-canonical Wnt signalling pathway. This gene is highly expressed during early embryonic development but expressed at very low levels in adult tissues. Increased expression of this gene is associated with B-cell chronic lymphocytic leukaemia. Alternative splicing results in multiple transcript variants encoding different isoforms.
  • Overview
  • scFv-Fc of anti-ROR1 Antibody, clone # R11
  • Clone #
  • R11
  • Species Reactivity
  • Human
  • Name
  • engineered selenocysteine (Sec) residue

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for ADC-W-434. Click the button above to contact us or submit your feedback about this product.

Quick Links

Online Inquiry

Name:
Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.